| Literature DB >> 19121652 |
Elisabeth Chéreau1, Dan Stefanescu, Frédéric Selle, Roman Rouzier, Emile Daraï.
Abstract
Recent studies have demonstrated efficacy of bevacizumab for recurrent ovarian cancer, but few data on its use and gastrointestinal potential complications when administered as adjuvant chemotherapy after cytoreductive surgery are available. In this study, we report the first case of a rectovaginal fistula in this indication.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19121652 DOI： 10.1016/j.ajog.2008.08.048
Source DB: PubMed Journal: Am J Obstet Gynecol ISSN： 0002-9378 Impact factor: 8.661